These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31468182)

  • 1. In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography.
    Bastin C; Bahri MA; Meyer F; Manard M; Delhaye E; Plenevaux A; Becker G; Seret A; Mella C; Giacomelli F; Degueldre C; Balteau E; Luxen A; Salmon E
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):390-402. PubMed ID: 31468182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [
    O'Dell RS; Mecca AP; Chen MK; Naganawa M; Toyonaga T; Lu Y; Godek TA; Harris JE; Bartlett HH; Banks ER; Kominek VL; Zhao W; Nabulsi NB; Ropchan J; Ye Y; Vander Wyk BC; Huang Y; Arnsten AFT; Carson RE; van Dyck CH
    Alzheimers Res Ther; 2021 Jan; 13(1):11. PubMed ID: 33402201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [
    Mecca AP; O'Dell RS; Sharp ES; Banks ER; Bartlett HH; Zhao W; Lipior S; Diepenbrock NG; Chen MK; Naganawa M; Toyonaga T; Nabulsi NB; Vander Wyk BC; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    Alzheimers Dement; 2022 Dec; 18(12):2527-2536. PubMed ID: 35174954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
    Mecca AP; Chen MK; O'Dell RS; Naganawa M; Toyonaga T; Godek TA; Harris JE; Bartlett HH; Zhao W; Nabulsi NB; Wyk BCV; Varma P; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    Alzheimers Dement; 2020 Jul; 16(7):974-982. PubMed ID: 32400950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J.
    Kumar A; Scarpa M; Nordberg A
    Alzheimers Dement; 2024 Apr; 20(4):2589-2605. PubMed ID: 38363009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [
    Andersen KB; Hansen AK; Damholdt MF; Horsager J; Skjaerbaek C; Gottrup H; Klit H; Schacht AC; Danielsen EH; Brooks DJ; Borghammer P
    Mov Disord; 2021 Sep; 36(9):2057-2065. PubMed ID: 33899255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [
    Vogler L; Ballweg A; Bohr B; Briel N; Wind K; Antons M; Kunze LH; Gnörich J; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Boening G; Ziegler SI; Levin J; Zwergal A; Höglinger GU; Herms J; Brendel M
    Neuroimage Clin; 2023; 39():103484. PubMed ID: 37541098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring brain synaptic vesicle protein 2A with positron emission tomography and [
    Bahri MA; Plenevaux A; Aerts J; Bastin C; Becker G; Mercier J; Valade A; Buchanan T; Mestdagh N; Ledoux D; Seret A; Luxen A; Salmon E
    Alzheimers Dement (N Y); 2017 Nov; 3(4):481-486. PubMed ID: 29124105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo tau pathology is associated with synaptic loss and altered synaptic function.
    Coomans EM; Schoonhoven DN; Tuncel H; Verfaillie SCJ; Wolters EE; Boellaard R; Ossenkoppele R; den Braber A; Scheper W; Schober P; Sweeney SP; Ryan JM; Schuit RC; Windhorst AD; Barkhof F; Scheltens P; Golla SSV; Hillebrand A; Gouw AA; van Berckel BNM
    Alzheimers Res Ther; 2021 Feb; 13(1):35. PubMed ID: 33546722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of synaptic density with [
    Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S
    Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain.
    Warnock GI; Aerts J; Bahri MA; Bretin F; Lemaire C; Giacomelli F; Mievis F; Mestdagh N; Buchanan T; Valade A; Mercier J; Wood M; Gillard M; Seret A; Luxen A; Salmon E; Plenevaux A
    J Nucl Med; 2014 Aug; 55(8):1336-41. PubMed ID: 24935992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principal component analysis of synaptic density measured with [
    O'Dell RS; Higgins-Chen A; Gupta D; Chen MK; Naganawa M; Toyonaga T; Lu Y; Ni G; Chupak A; Zhao W; Salardini E; Nabulsi NB; Huang Y; Arnsten AFT; Carson RE; van Dyck CH; Mecca AP
    Neuroimage Clin; 2023; 39():103457. PubMed ID: 37422964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease.
    Hamelin L; Lagarde J; Dorothée G; Potier MC; Corlier F; Kuhnast B; Caillé F; Dubois B; Fillon L; Chupin M; Bottlaender M; Sarazin M
    Brain; 2018 Jun; 141(6):1855-1870. PubMed ID: 29608645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Synaptic Density Imaging with
    Toyonaga T; Smith LM; Finnema SJ; Gallezot JD; Naganawa M; Bini J; Mulnix T; Cai Z; Ropchan J; Huang Y; Strittmatter SM; Carson RE
    J Nucl Med; 2019 Dec; 60(12):1780-1786. PubMed ID: 31101744
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of [
    Chen MK; Mecca AP; Naganawa M; Gallezot JD; Toyonaga T; Mondal J; Finnema SJ; Lin SF; O'Dell RS; McDonald JW; Michalak HR; Vander Wyk B; Nabulsi NB; Huang Y; Arnsten AF; van Dyck CH; Carson RE
    J Cereb Blood Flow Metab; 2021 Sep; 41(9):2395-2409. PubMed ID: 33757318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vivo evaluation of [
    Li S; Cai Z; Zhang W; Holden D; Lin SF; Finnema SJ; Shirali A; Ropchan J; Carre S; Mercier J; Carson RE; Nabulsi N; Huang Y
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1952-1965. PubMed ID: 31175396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.